Is Integrated Biopharma Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Integrated Biopharma Inc (INBP) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Integrated Biopharma Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Integrated Biopharma Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Integrated Biopharma Inc?

Muslim investors may consider investing in Integrated Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Integrated Biopharma Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Integrated Biopharma Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Integrated Biopharma Inc updated?

The Shariah compliance status of Integrated Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Integrated Biopharma Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Integrated Biopharma Inc?

You can check the latest Shariah compliance status of Integrated Biopharma Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Integrated Biopharma Inc. Stock Analysis INBP

United States Consumer Staples Nano Cap

Integrated BioPharma, Inc. engages in the manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products. The company is headquartered in Hillside, New Jersey and currently employs 153 full-time employees. The Company’s business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and Other Business Lines which include the operations of MDC Warehousing and Distribution, Inc. (MDCWHD), a service provider for warehousing and fulfillment services, and Chem International, Inc. (Chem), a distributor of certain raw materials for DSM Nutritional Products LLC and the holding entity of the Company.

Key Statistics of Integrated Biopharma Inc (INBP)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.21$0.21

Today's Open

$0.21

Volume

38.70K

P/E Ratio (TTM)

8.39

52 Week Range

$0.21$0.42

Market Cap

7.84M

Avg. Volume

12.76K

Dividend Yield

Financial Metrics & Statements of Integrated Biopharma Inc (INBP)

FAQ's for Integrated Biopharma Inc (INBP)

According to Musaffa’s Shariah screening methodology, Integrated Biopharma Inc (INBP) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.